Summary & Overview
HCPCS Level II M1305: Adult Pneumococcal Vaccination
HCPCS Level II code M1305 captures administration of any pneumococcal conjugate or polysaccharide vaccine given to an individual aged 19 years or older within the measurement period. This preventive immunization code is used to document adult pneumococcal vaccination status for reporting and quality measurement. Nationally, pneumococcal vaccination is a key public health measure to reduce invasive pneumococcal disease, especially among older adults and those with chronic conditions.
Key payers included in this analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of what M1305 represents, where the service is typically delivered, and which payers commonly recognize the code. The publication outlines benchmark usage and reporting contexts, recent policy considerations affecting adult immunization documentation, and clinical context regarding pneumococcal vaccine types (conjugate and polysaccharide) relevant to adult care.
This summary provides a practical reference for coding, billing, and quality measurement staff seeking clear national-level context for M1305, including expected service settings and the role of the code in vaccination reporting and preventive care programs. Data not available in the input.
Billing Code Overview
HCPCS Level II code M1305 documents that a patient received any pneumococcal conjugate or polysaccharide vaccine on or after their 19th birthday and before the end of the measurement period. This code represents vaccination administration for adults eligible for pneumococcal immunization.
-
Service type: Immunization administration for pneumococcal vaccine
-
Typical site of service: Outpatient clinics, community vaccination sites, primary care offices, and pharmacies
Clinical & Coding Specifications
Clinical Context
A 67-year-old patient presents to a primary care clinic during an annual wellness visit. The patient’s immunization record is reviewed and it is determined they are due for pneumococcal vaccination on or after their 19th birthday and within the measurement period. The nurse verifies prior pneumococcal vaccine history, screens for contraindications (severe allergic reaction to a previous pneumococcal vaccine component), and documents informed consent. The vaccine (either pneumococcal conjugate or polysaccharide) is administered intramuscularly in the deltoid; lot number, expiration date, manufacturer, route, site, and VIS (Vaccine Information Statement) date are recorded in the medical record and immunization registry. Billing is submitted using HCPCS Level II code M1305 to indicate receipt of any pneumococcal conjugate or polysaccharide vaccine administered on or after the patient’s 19th birthday during the measurement period. Typical workflow participants include the front-desk staff (scheduling and insurance verification), clinical nursing staff (screening, administration, documentation), and the ordering provider (review and authorization). Typical follow-up includes monitoring for immediate adverse reactions for 15 minutes and scheduling any required subsequent doses per CDC guidance.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when administration required substantially greater resources due to unusual circumstances (rare for vaccine administration). |